Abbott Laboratories (ABL) - Financials, balance sheet (annual)

119.52000 EUR

0.9

0.76%

Last update May 12, 7:37 PM CEST

Main market

Day range

119.52000

118.56000

120.32000

Previous close

118.62000

Open

118.56000

Access this stock data via API

Abbott Laboratories

119.52

0.90

0.76%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	81.4B	73.2B	74.4B	75.2B
Current assets	23.7B	22.7B	25.2B	24.2B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	7.6B	6.9B	9.9B	9.8B
Other short term investments	351M	383M	288M	450M
Accounts receivable	6.9B	6.6B	6.2B	6.5B
Other receivables	2.6B	2.3B	2.7B	2.3B
Inventory	6.2B	6.6B	6.2B	5.2B
Prepaid assets	—	—	—	2.3B
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	57.8B	50.5B	49.2B	51.0B
Properties	15.5B	15.2B	14.2B	13.5B
Land and improvements	528M	529M	511M	525M
Machinery furniture equipment	—	—	—	13.5B
Construction in progress	2.5B	2.1B	1.5B	1.3B
Leases	—	—	—	—
Accumulated depreciation	-12.1B	-11.8B	-11.1B	-10.4B
Goodwill	52.9B	56.2B	56.1B	59.2B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	6.6B	8.8B	10.5B	12.7B
Investments and advances	886M	799M	766M	816M
Other non current assets	16.5B	7.1B	12.1B	10.4B
Total liabilities	33.5B	34.4B	37.5B	39.2B
Current liabilities	14.2B	13.8B	15.5B	13.1B
Accounts payable	4.2B	4.3B	4.6B	4.4B
Accrued expenses	6.2B	6.4B	6.8B	6.4B
Short term debt	1.5B	1.1B	2.3B	754M
Deferred revenue	—	—	—	—
Tax payable	594M	492M	343M	306M
Pensions	—	—	—	—
Other current liabilities	—	—	—	—
Non current liabilities	19.4B	20.5B	22.0B	26.1B
Long term provisions	—	—	—	—
Long term debt	13.5B	14.5B	15.5B	18.3B
Provision for risks and charges	—	—	—	—
Deferred liabilities	512M	568M	991M	1.4B
Derivative product liabilities	—	—	—	—
Other non current liabilities	3.4B	3.5B	3.8B	3.7B
Shareholders equity
Common stock	25.2B	24.9B	24.7B	24.5B
Retained earnings	47.3B	37.6B	35.3B	31.5B
Other shareholders equity	-7.9B	-7.8B	-8.1B	-8.4B
Total shareholders equity	47.9B	38.8B	36.9B	36.0B
Additional paid in capital	—	—	—	—
Treasury stock	16.8B	16.0B	15.2B	11.8B
Minority interest	237M	224M	219M	222M